You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Aquestive Therapeutics Inc - Company Information, Overview, History and Profile

What does Aquestive Therapeutics Inc do?

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Aquestive Therapeutics Inc Management structure

All Gross Remunerations are in USD
Ms. Cassie Jung
Chief Operating Officer
-
2024
Gross Remuneration
Year
Mr. Daniel Barber
Chief Executive Officer, President and Director
-
2024
Gross Remuneration
Year
Mr. A. Ernest Toth, Jr
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
-
2024
Gross Remuneration
Year

Aquestive Therapeutics Inc Board of directors

All Gross Remunerations are in USD
Ms. Abigail L. Jenkins, B.A.,M.S.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Santo J. Costa
Independent Director
-
2024
Gross Remuneration
Year
Dr. Gregory B. Brown,M.D.
Chairman of the Board
-
2024
Gross Remuneration
Year
Mr. Timothy E. Morris
Independent Director
-
2024
Gross Remuneration
Year
Dr. Marco Taglietti,M.D.
Independent Director
-
2024
Gross Remuneration
Year
Dr. Julie Krop, M.D.
Independent Director
-
2024
Gross Remuneration
Year